Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-05-25 4:24 pm Sale |
2021-05-20 | 13D | Innoviva, Inc. INVA |
GLAXOSMITHKLINE PLC | 0 0.000% |
-32,005,260 (Position Closed) |
Filing History |
| 2021-05-03 5:19 pm Purchase |
2021-05-03 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Innoviva Inc. INVA |
44,807,844 70.600% |
7,462,050 (+19.98%) |
Filing History |
| 2021-04-05 5:07 pm Sale |
2021-04-01 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
0 0.000% |
-29,729,294 (Position Closed) |
Filing History |
| 2021-03-17 5:17 pm Purchase |
2021-03-17 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
29,729,294 74.700% |
8,571,870 (+40.51%) |
Filing History |
| 2021-02-12 5:13 pm Unchanged |
2021-02-12 | 13D | Innoviva, Inc. INVA |
GLAXOSMITHKLINE PLC | 32,005,260 31.600% |
0 (Unchanged) |
Filing History |
| 2021-02-11 09:42 am Sale |
2020-12-31 | 13G | Innoviva, Inc. INVA |
Renaissance Technologies LLC | 7,881,802 7.770% |
-11,895 (-0.15%) |
Filing History |
| 2021-02-10 11:03 am Sale |
2020-12-31 | 13G | Innoviva, Inc. INVA |
The Vanguard Group | 6,595,483 6.500% |
-211,456 (-3.11%) |
Filing History |
| 2021-01-27 5:30 pm Purchase |
2021-01-26 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
21,157,424 68.000% |
3,735,824 (+21.44%) |
Filing History |
| 2021-01-26 6:52 pm Sale |
2020-12-31 | 13G | Innoviva, Inc. INVA |
BLACKROCK INC BLK |
11,160,546 11.000% |
-337,500 (-2.94%) |
Filing History |
| 2020-12-14 08:03 am Purchase |
2020-12-11 | 13D | Innoviva, Inc. INVA |
Sarissa Capital Management LP | 6,414,000 6.330% |
617,900 (+10.66%) |
Filing History |
| 2020-09-01 5:28 pm Purchase |
2020-09-01 | 13D | Entasis Therapeutics Holdings Inc. ETTX |
Innoviva Inc. INVA |
37,345,794 69.000% |
34,700,774 (+1311.93%) |
Filing History |
| 2020-08-31 3:10 pm Unchanged |
2020-08-27 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
28,000,000 67.800% |
0 (Unchanged) |
Filing History |
| 2020-06-12 5:30 pm Purchase |
2020-06-11 | 13D | Armata Pharmaceuticals, Inc. ARMP |
Innoviva Inc. INVA |
28,000,000 67.800% |
28,000,000 (New Position) |
Filing History |